All Type of News
SK Chemicals approve commercialization of Xarelto generic for first timeThe first generic of novel oral anticoagulant(NOAC), which is rapidly invading the warfarin prescription market, was domestically approved.
Under the Patent-Linkage system, th...
|
Boksan Nice attracts KRW 52 billion investment from Japanese Suzuken
A domestic pharmaceutical distribution company succeeded in attracting a large-scale investment once again.
Boksan Nice Pharm(President Tae-eung Um) announced it has concluded a business and capital agreement with Su...
Concerning KPA’s responses to current pharmaceutical issues
Since the government announced expansion of the number of emergency household drugs to be sold in convenient stores, the industry highly concerns if the Korean Pharmaceutical Association(KPA) has made proper responses...
Japanese pharmaceutical companies record KRW 911.7 billion sales increased by 14.2%
Japanese multinational pharmaceutical companies branched in Korea continued upturns in the domestic market last year.
According to the analysis result of 8 Japanese companies’(6 companies and 12 companies balancing ...
‘Keytruda’ administration test method accepted as new medical technology
A diagnostic check method which is used to decide administration of ‘Keytruda(pembrolizumab),’ an immunotherapy which attracted interests over the health insurance benefit, will be accepted as a new medical technology...
Kyowa Hakko Kirin Korea appoint Suzuki as new CEO
On the 6th, the Japanese multinational pharmaceutical company, Kyowa Hakko Kirin Korea, announced appointment of Suzuki Shigeaki as a new CEO from the 1st of July.
Shigeaki Suzuki, the new CEO, is known as a profess...
MOHW, “We are discussing about expansion of number of household drugs in convenient stores”
The Ministry of Health and Welfare(MOHW) seems it will push forward with expansion of the number of emergency household drugs in convenient stores.
On the 5th, the MOHW announced it has conducted outsourced researche...
“I expect the role of LAI Invega Trinza on schizophrenia”
In the market of schizophrenia, whose key of treatment is to prevent recurrence prevention, the domestic approval of ‘Invega Trinza,’ a long-acting injection(hereinafter referring to LAI), has attracted attention.
At...
Series of large pharmaceutical companies to establish venture capital firms
The top-ranked domestic pharmaceutical companies drew attention as establishing investment companies to support ventures for new drug development. Their purpose is to secure promising pipelines through the open innova...
AstraZeneca’s sharp conflicts between labor and management over reorganizationAstraZeneca Korea has suffered from conflicts against its labor union in the process of personnel reorganization.
AstraZeneca Korea conducted the ERP(Early Retirement Program) ...
|
